Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2451346rdf:typepubmed:Citationlld:pubmed
pubmed-article:2451346lifeskim:mentionsumls-concept:C1623048lld:lifeskim
pubmed-article:2451346lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:2451346lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:2451346lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:2451346lifeskim:mentionsumls-concept:C0162735lld:lifeskim
pubmed-article:2451346lifeskim:mentionsumls-concept:C1446680lld:lifeskim
pubmed-article:2451346lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:2451346lifeskim:mentionsumls-concept:C0449943lld:lifeskim
pubmed-article:2451346lifeskim:mentionsumls-concept:C1707391lld:lifeskim
pubmed-article:2451346lifeskim:mentionsumls-concept:C0027971lld:lifeskim
pubmed-article:2451346pubmed:issue2lld:pubmed
pubmed-article:2451346pubmed:dateCreated1988-5-2lld:pubmed
pubmed-article:2451346pubmed:abstractTextAntigenic variants of the New Jersey serotype of vesicular stomatitis virus (VSV-NJ) were isolated and cloned by selecting virus plaques resistant to neutralization by high-titered monoclonal antibodies (MAbs) directed to glycoprotein (G) epitopes V, VI, VII, or VIII. The G proteins of each neutralization-resistant virus variant also exhibited markedly reduced antigenic reactivity with each corresponding epitope-specific MAb as determined by enzyme-linked immuno-absorbent assay and by Western blot analysis. Loss of antigenic reactivity of certain mutant G proteins to a MAb other than the one used to select the mutant virus suggested close antigenic proximity, particularly for epitopes VI and VII. The virion RNAs coding for the entire G gene of the wild-type virus and 10 MAb-induced mutants were sequenced by primer DNA extension using the dideoxy method. Each mutant G gene exhibited only a single nucleotide change, leading in each case to a single amino acid substitution, as follows: Glu210----Lys for all three mutants selected by MAb14 (epitope VII); Pro268----Thr for one mutant selected by MAb12 (epitope VI); Ser277----Lys for all three mutants selected by MAb15 (epitope VIII); and Glu364----Lys for all three mutants selected by MAb11 (epitope V). These neutralizing MAb-selected mutations are clustered in the middle third of the 517-amino acid VSV-NJ G protein, presumably resulting in conformational changes that alter recognition of one or more antigenic determinants by a specific monoclonal antibody.lld:pubmed
pubmed-article:2451346pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:languageenglld:pubmed
pubmed-article:2451346pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:citationSubsetIMlld:pubmed
pubmed-article:2451346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2451346pubmed:statusMEDLINElld:pubmed
pubmed-article:2451346pubmed:monthAprlld:pubmed
pubmed-article:2451346pubmed:issn0042-6822lld:pubmed
pubmed-article:2451346pubmed:authorpubmed-author:LUMMlld:pubmed
pubmed-article:2451346pubmed:authorpubmed-author:WagnerR RRRlld:pubmed
pubmed-article:2451346pubmed:authorpubmed-author:SnyderR MRMlld:pubmed
pubmed-article:2451346pubmed:authorpubmed-author:WULLlld:pubmed
pubmed-article:2451346pubmed:issnTypePrintlld:pubmed
pubmed-article:2451346pubmed:volume163lld:pubmed
pubmed-article:2451346pubmed:ownerNLMlld:pubmed
pubmed-article:2451346pubmed:authorsCompleteYlld:pubmed
pubmed-article:2451346pubmed:pagination341-8lld:pubmed
pubmed-article:2451346pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:meshHeadingpubmed-meshheading:2451346-...lld:pubmed
pubmed-article:2451346pubmed:year1988lld:pubmed
pubmed-article:2451346pubmed:articleTitlePoint mutations in glycoprotein gene of vesicular stomatitis virus (New Jersey serotype) selected by resistance to neutralization by epitope-specific monoclonal antibodies.lld:pubmed
pubmed-article:2451346pubmed:affiliationDepartment of Microbiology and Cancer Center, University of Virginia School of Medicine, Charlottesville 22908.lld:pubmed
pubmed-article:2451346pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2451346pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2451346pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2451346lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2451346lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2451346lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2451346lld:pubmed